Treasury stock

Travis Perkins: Total Voting Rights

Tuesday, December 1, 2020 - 9:01am

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

GOGL – Declaration of options

Monday, November 30, 2020 - 6:40pm

The Board of Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (Golden Ocean or the Company) announced an option holder has exercised options to acquire 50,000 shares in the Company in accordance with the terms previously disclosed.

Key Points: 
  • The Board of Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (Golden Ocean or the Company) announced an option holder has exercised options to acquire 50,000 shares in the Company in accordance with the terms previously disclosed.
  • The option exercise will be settled in full with treasury shares held by the Company.
  • Following the delivery of the shares, Golden Ocean will hold a total of 945,000 treasury shares.
  • This information is subject to the disclosure requirements of section 5-12 of the Norwegian Securities Trading Act.

Santhera Completes Capital Increase for Financing Arrangements

Wednesday, November 25, 2020 - 6:00am

Pratteln, Switzerland, November25, 2020 Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 937,928 treasury shares.

Key Points: 
  • Pratteln, Switzerland, November25, 2020 Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 937,928 treasury shares.
  • On November24, 2020, 937,928 shares were issued out of the existing authorized capital as treasury shares.
  • Santhera expects to use these shares for purposes of its financing arrangements.
  • For further information please contact:
    This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Santhera Pharmaceuticals Holding AG.

Naspers Limited’s (JSE: NPN; LSE: NPSN) Subsidiary Prosus Today Announced Launch of Share Repurchase and Share Purchase

Monday, November 23, 2020 - 5:57am

Shareholders are referred to the announcement issued by Nasperss subsidiary Prosus N.V. (Prosus) today in respect of the launch of:

Key Points: 
  • Shareholders are referred to the announcement issued by Nasperss subsidiary Prosus N.V. (Prosus) today in respect of the launch of:
    an on-market Naspers Limited (Naspers) N ordinary share purchase programme of up to US$3.63 billion (the Share Purchase, together with the Share Repurchase, the Transaction).
  • The Naspers N ordinary shares held by Prosus after having been purchased under the Share Purchase will constitute treasury shares under the JSE Listings Requirements.
  • Prosus intends not to exercise any voting rights attaching to the Naspers N ordinary shares acquired under the Share Purchase.
  • The Share Purchase by Prosus constitutes a general repurchase of securities under the JSE Listings Requirements and will be implemented accordingly.

Ahold Delhaize authorizes new €1 billion share buyback program for 2021

Wednesday, November 4, 2020 - 6:46am

Zaandam, the Netherlands,November 4, 2020AholdDelhaize today announcesthe authorization ofa new 1 billion share buyback program, tostart at the beginning of 2021.

Key Points: 
  • Zaandam, the Netherlands,November 4, 2020AholdDelhaize today announcesthe authorization ofa new 1 billion share buyback program, tostart at the beginning of 2021.
  • The new program is a testament to the strength the company expects to continue to see in its business model.
  • The share buyback program is executed in several tranches.
  • Shares are bought in the market and accumulated on the treasury share account until cancellation.

AEW UK REIT plc: Transaction in Own Shares

Tuesday, November 3, 2020 - 6:02pm

The Company announces that on 3 November 2020 it purchased 150,000 Ordinary Shares of 1p each in the capital of the Company at a highest price of 73.5p per Ordinary Share and a lowest price of 73p per Ordinary Share.

Key Points: 
  • The Company announces that on 3 November 2020 it purchased 150,000 Ordinary Shares of 1p each in the capital of the Company at a highest price of 73.5p per Ordinary Share and a lowest price of 73p per Ordinary Share.
  • Following the transaction, the Company's issued share capital is 158,774,746 Ordinary Shares.
  • The Company holds 350,000 Ordinary Shares in treasury, which do not carry any voting rights.
  • Accordingly, the total number of voting rights in the Company is 158,424,746 Ordinary Shares.

Travis Perkins: Total Voting Rights

Monday, November 2, 2020 - 10:01am

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

Nidec Announces the Status of Own Share Repurchase

Monday, November 2, 2020 - 6:30am

Period of own share repurchase: From October 1, 2020 through October 31, 2020

Key Points: 
  • Period of own share repurchase: From October 1, 2020 through October 31, 2020
    Number of own shares repurchased: 0
    Note: The above repurchase information has been prepared on the basis of trade date.
  • The following details were resolved by the Companys Board of Directors on January 23, 2020 and February 8, 2020:
    Total number of shares that may be repurchased: Up to 8,000,000 shares
    (1.36% of total number of shares issued, excluding treasury stock)

Santhera Completes Capital Increase for Financing Arrangements

Thursday, October 22, 2020 - 6:00am

Pratteln, Switzerland, October22, 2020 Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 1,011,363 reserve shares.

Key Points: 
  • Pratteln, Switzerland, October22, 2020 Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 1,011,363 reserve shares.
  • On October21, 2020, 1,011,363 shares were issued out of the existing authorized capital as treasury shares.
  • Santhera expects to use these shares for its financing arrangements and/or for general financing purposes.
  • For further information please contact:
    This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Santhera Pharmaceuticals Holding AG.

Sports Venues of Florida, Inc. (OTC:BTHR) Announces Reduction in Authorized Common Stock By 6.56 Billion Shares Effective October 15, 2020 -- Existing Shareholders Not Affected by This Corporate Action

Monday, October 19, 2020 - 1:00pm

The Company did not reverse its issued and outstanding common stock so existing shareholders will not be affected by this corporate action.

Key Points: 
  • The Company did not reverse its issued and outstanding common stock so existing shareholders will not be affected by this corporate action.
  • Management has listened to comments from its shareholders and a common theme shared by many was that the Company had too many authorized shares.
  • Management wants to provide comfort to its current and future shareholders that they have no plans on extensive dilution in the future.
  • The Company does not need billions and billions of authorized shares that serve no purpose other than making shareholders and prospective shareholders nervous.